Hikma Pharmaceuticals

Discover out #Hikma#Manufacturing #Footprint. In #Tunisia, Hikma has been present for over 34 years, with three manufacturing plants dedicated to improving local health outcomes. We manufacture medicines across eight therapeutic areas, continually working together to put better health within reach, every day. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #MENA

On #WorldCancerDay, our purpose at Hikma to improve patient outcomes by putting better health within reach every day, feels ever more important. Always driven and inspired by this purpose, we champion the collective movement to support those impacted by cancer. By leveraging our strategic partnerships, we drive important and meaningful improvements in the care of cancer patients. Our global reach enables us to bridge gaps, introducing cutting-edge healthcare solutions for patients in the MENA region, while our deep local expertise addresses the needs of the people in our communities. Because we know, every cancer journey is unique. #Hikma #CancerCare #UnitedByUnique

Discover our #Hikma R&D Footprint. Our injectable R&D facility in #Zagreb #Croatia is dedicated to the development of complex and differentiated injectable products, primarily in ready-to-use formulations. We are investing in our R&D capabilities to ensure that our pipeline reflects the future needs of our customers and patients. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #RD #Injectables

#News for #media and #investors We are proud to announce the signing of a strategic Memorandum of Understanding (MoU) with M42 Health at Arab Health 2025. This collaboration strengthens our efforts in promoting Shield™, a US FDA-approved, non-invasive blood test for colorectal cancer screening. This MoU supports healthcare #innovation in the #UAE through more precise, preventive, and predictive cancer care programmes, using cutting-edge genomics technology for early cancer detection, to improve treatment outcomes. Read the full press release: https://lnkd.in/d7z95ysB #BetterHealth #WithinReach #EveryDay #Oncology #PrecisionMedicine Picture 1 (L-R): Signatories: Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA - Hikma Pharmaceuticals and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42. Witnesses: Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals and Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42. Picture 2 (L-R): Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals, Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA – Hikma Pharmaceuticals, Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42 and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42.

Meet Nika Beck, Manufacturing Specialist at Hikma 503B, and discover how she champions quality to put better health within reach, every day at #hikma Learn more: https://brnw.ch/21wQh7o #DistinctlyHikmaQuality #Quality #MeetOurTeam #BetterHealth #HikmaUS

Discover our #Hikma #Manufacturing #Footprint. Our plant in #Goslar, #Germany, serves as a hub for liquid and lyophilisation cytotoxic production for the US, Europe, and MENA. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the communities we serve. Read more about our expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #Europe #Injectables

On #InternationalDayofEducation, we reaffirm our commitment to education as a key part of our sustainability agenda. Providing educational programmes is a priority in our corporate social responsibility efforts. We collaborate with universities, schools, and community organisations to offer better learning opportunities, essential supplies, and classroom renovations. #Health #Wellbeing #Education #Hikma #Sustainability Read more: https://brnw.ch/21wQdtP

Discover our #Hikma #Manufacturing #Footprint. Our #Sintra, #Portugal site is the global hub for our Injectables business. It has three plants with complex manufacturing technologies and the ability to produce general formulations, high containment products and cephalosporins. With over 900 employees, this site has been meeting our evolving customer needs in the US, EU, and MENA for over 35 years. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the communities we serve. Read more about our expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #Europe #Healthcare #Injectables

Discover our #HikmaFootprint. For over 30 years, Hikma #Algeria has been supporting healthcare needs of patients in the country with a diversified portfolio of medicines covering eight therapeutic areas to address a wide range of healthcare needs. Operating four manufacturing plants we are investing in building more local capabilities to continue to improve access to essential medicine. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #MENA

Discover our #HikmaFootprint. Our #Cherry Hill, NJ site in the #US produces injectable medicines of various strengths and dosage forms, including prefilled syringes. We have more than 600 dedicated employees who work diligently to ensure an uninterrupted supply of essential medicines that hospitals, physicians, and pharmacists rely on to treat patients. We leverage our extensive high-quality manufacturing capabilities and global reach to deliver meaningful impact in the communities we serve. Read more about our local expertise: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #NewJersey #Injectables #Prefilled